| Purpose | Board Meetings Date | Announcement Date |
|---|---|---|
| Board Meeting | 8 May 2025 | 30 Apr 2025 |
| Medico Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 08/05/2025 inter alia to consider and approve Audited Financial Results for the quarter and year ended 31st March 2025. Please find attached Outcome of Board Meeting held today Please find attached Intimation for Cessation of Term of VJ Shah & Co as Statutory Auditors of the Company. Please find attached Financial Results for quarter and year ended 31st March, 2025. Please find attached Intimation for appointment of Mr. Haresh Sanghvi as Secretarial Auditor and approval of Directors Report alongwith Annexures. (As Per BSE Announcement Dated on 08.05.2025) | ||
| Board Meeting | 5 Feb 2025 | 30 Jan 2025 |
| Medico Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2025 inter alia to consider and approve Unaudited Financial Results for the Quarter and Nine months ended 31st December 2024 along with the Limited Review Report thereon; Please find attached Results for December, 2024. (As per BSE Announcement Dated on 05/02/2025) | ||
| Board Meeting | 26 Dec 2024 | 26 Dec 2024 |
| Please find attached Outcome of Board Meeting held today | ||
| Board Meeting | 12 Nov 2024 | 6 Nov 2024 |
| Medico Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2024 inter alia to consider and approve Unaudited Financial Results for the quarter and half year ended 30th September 2024 along with the Limited Review Report thereon Outcome of Board Meeting held today Please find attached Outcome of Board Meeting held today (As Per BSE Announcement Dated on 12.11.2024) | ||
| Board Meeting | 12 Aug 2024 | 5 Aug 2024 |
| Medico Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 inter alia to consider and approve 1. Unaudited Financial Results for the quarter ended 30th June 2024 along with the Limited Review Report thereon; 2. Any other business with the permission of the Chair. Financial Results for Quarter ended June, 2024 (As Per BSE Announcement dated on 12.08.2024) | ||
Invest wise with Expert advice
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2025, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
